Advertisement

Journal of Neuro-Oncology

, Volume 6, Issue 2, pp 119–128 | Cite as

Tumor cord and growth in human brain tumors based on mathematical morphology

  • Yoshihiko Yoshii
  • Kiyoshi Narushima
  • Koji Tsuboi
  • Yutaka Maki
  • Kohei Sugiyama
Article

Summary

The growth of human brain tumor was quantitatively investigated by using the anti-bromodeoxyuridine (BrdU) monoclonal antibody and the texture analyzing system (TAS). Tissues from thirty eight patients consisting of 22 gliomas, 8 brain metastases, 1 cerebellar hemangioblastoma and 7 normal white matters were applied in this study. Mean values of growth fractions (GFs) were 29.4% in group 1, 14.8% in group 2, and 6.5% in group 3. The higher value of GFs showed a significantly larger degree of perivascular aggregation of S-phase cells (DPAS). The mean number of cells in each tumor cord was approximately 20, which is not significantly larger than that of the normal group. But there was a significant difference between the non-selected area of the histologically malignant or benign gliomas and the proliferating area of the biologically malignant or benign brain tumors (t-value; p<0.001). A significant difference was also noticed in the mean area and diameter of tumor cords (t-value; p<0.001).

From the point of view of biological behavior in human brain tumor, it is suggested that one tumor cord contains approximately 20 viable cells in the proliferating area in both benign and malignant brain tumors, and that if viable cells increase to more than 20 cells in one TC, necrotic cells and the diameter and area of the TC will increase, because the vessel-density is decreased by the occlusion of the vessels and the death of the endothels.

Key words

human brain tumor anti-BrdU monoclonal antibody tumor cord texture analyzing computer system (TAS) mathematical morphology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baserga R: The cell cycle and cancer. Marcel Dekker, New York, 1971Google Scholar
  2. 2.
    Cox DJ, Pilkington GJ, Lantos PL: The fine structure of blood vessels in ethylnitrosourea-induced tumors of the rat nervous system — With special reference to the breakdown of the blood-brain barrier. Brit J exp Path 57:419–430, 1976PubMedGoogle Scholar
  3. 3.
    Davidson RL, Kaufman ER, Dougherty CP, Ouellette AM, Difolco CM, Latt SA: Induction of sister chromatid exchanges by BUdR is largely independent of the BUdR content of DNA. Nature 284:74–76, 1980CrossRefPubMedGoogle Scholar
  4. 4.
    Deane BR, Lantos PL: The vasculature of experimental brain tumours. (Part 1) A sequential light and electron microscope study of angiogenesis. J Neuroi Sci 49:55–66, 1981Google Scholar
  5. 5.
    Deane BR, Lantos PL: The vasculature of experimental brain tumours. (Part 2) A quantitative assessment of morphological abnormalities. J Neurol Sci 49:67–77, 1981PubMedGoogle Scholar
  6. 6.
    Folkman J: Tumor angiogenesis — Therapeutic implications. New Engl J Med 285:1182–1186, 1971PubMedGoogle Scholar
  7. 7.
    Fujita T: Vascularization in infantile brain tumors induced by human adenovirus type 12 in rats. Acta Pathol Jpn 34:1343–1354, 1984PubMedGoogle Scholar
  8. 8.
    Gellatly BJ, Finney JL: Calculation of protein volumes: An alternative to the Voronoi procedure. J Mol Biol 161:305–322, 1982CrossRefPubMedGoogle Scholar
  9. 9.
    Gimbrone MA, Cotran RS, Folkman J: Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136:261–276, 1972CrossRefPubMedGoogle Scholar
  10. 10.
    Goz B: The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells. Pharmacol Rev 29:249–272, 1978Google Scholar
  11. 11.
    Gratzner HG: Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218:474–476, 1982PubMedGoogle Scholar
  12. 12.
    Hardman J: Angioarchitecture of gliomata. Brain 63:91–118, 1966Google Scholar
  13. 13.
    Hirano A, Matsui T: Vascular structures in brain tumors. Hum Path 6:611–621, 1975PubMedGoogle Scholar
  14. 14.
    Hirst DG, Denekamp J: Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet 12:31–42, 1975Google Scholar
  15. 15.
    Hoshino T, Barker M, Wilson CB, Boldrey EB, Fewer D: Cell kinetics of human gliomas. J. Neurosurg 37:15–26, 1972PubMedGoogle Scholar
  16. 16.
    Hoshino T, Wilson CB, Rosenblum ML, Barker M: Chemotherapeutic implications of growth fraction and cell cycle time in glioblastoma. J Neurosurg 43:127–135, 1975PubMedGoogle Scholar
  17. 17.
    Hoshino T, Wilson CB: Cell kinetic analyses of human malignant brain tumors (gliomas). Cancer 44:956–962, 1979PubMedGoogle Scholar
  18. 18.
    Hoshino T, Townsend JJ, Muraoka I, Wilson CB: An autoradiographic study of human gliomas: growth kinetics of anaplastic astrocytoma and glioblastoma multiforme. Brain 103:967–984, 1980PubMedGoogle Scholar
  19. 19.
    Howard A, Pelc SR: Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity (suppl) 6:261–273, 1953Google Scholar
  20. 20.
    Johnson HA, Haymaker WE, Rubini JR, Fliedner TM, Bond VP, Cronkite EP, Hughes WL: A radioautographic study of a human brain and glioblastoma multiforme after the in vivo uptake of tritiated thymidine. Cancer 13:636–642, 1960PubMedGoogle Scholar
  21. 21.
    Kelly PJ, Suddith RL, Hutchinson HT, Werrbach K, Haber B: Endothelial growth factor present in tissue culture of CNS tumors. J Neurosurg 44:342–346, 1976PubMedGoogle Scholar
  22. 22.
    Kinsella TJ, Russo A, Mitchell JB, Rowland J, Jenkins J, Schwade J, Myers CE, Collins JM, Speyer J, Kornblith P, Smith B, Kufta C, Gladstein EA: A phase I study of intermittent intravenous bromodeoxyuridine (BUDR) with conventional fractionated irradiation. Int J Radiat Oncol Biol Phys 10:69–76, 1985Google Scholar
  23. 23.
    Kury G, Carter HD: Autoradiographic study of human nervous system tumors. Arch Path 80:38–42, 1965Google Scholar
  24. 24.
    Levin VA, Landahl HD, Patlak CS: Drug delivery to CNS tumors. Cancer Treat Rep 65 (suppl 2):19–25, 1981PubMedGoogle Scholar
  25. 25.
    Long D: Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J Neurosurg 32:127–144, 1970PubMedGoogle Scholar
  26. 26.
    Luthert PJ, Lantos PL: A morphometric study of the microvasculature of a rat glioma. Neuropath appli Neurobiol 11:461–473, 1985Google Scholar
  27. 27.
    McAuslan BR, Hoffman H: Endothelium stimulating factor from Walker carcinoma cells — Relation to tumor angiogenesis factor. Exp Cell Res 119:181–190, 1979CrossRefPubMedGoogle Scholar
  28. 28.
    Mendelsohn ML: Autoradiographic analysis of cell proliferation in spontaneous breast cancer of C3H mouse. III. The growth fraction. J Natl Cancer Inst 28:1015–1029, 1962PubMedGoogle Scholar
  29. 29.
    Mitchell JB, Kinsella TS, Russo A, McPherson S, Rowland J, Kornblith P, Gladstein E: Radiosensitization of hematoprietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR). Int J Radiat Oncol Biol Phys 9:457–463, 1983PubMedGoogle Scholar
  30. 30.
    Moore JV, Hopkins HA, Looney WB: Response of cell populations in tumor cords to a single dose of cyclophosphamide or radiation. Eur J Cancer Clin Oncol 19:73–79, 1983CrossRefPubMedGoogle Scholar
  31. 31.
    Nagashima T, Hoshino T: Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ. Acta Neuropathol (Berl) 66:12–17, 1985Google Scholar
  32. 32.
    Nagashima T, DeArmond SJ, Murovic J, Hoshino T: Immunocytochemical demonstration of S-phase cells by antibormodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol (Berl) 67:155–159, 1985Google Scholar
  33. 33.
    Rabes HM, Carl P, Meister P, Pattenhuber U: Analysis of proliferative compartments in human tumors. I. Renal adenocarcinoma. Cancer 44:799–813, 1979PubMedGoogle Scholar
  34. 34.
    Reese TS, Karnovsky MJ: Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 34:207–217, 1967CrossRefPubMedGoogle Scholar
  35. 35.
    Russo A, Gianni L, Kinsella TJ, Klecker RW, Jenkins J, Rowland J, Gladstein E, Mitchell JB, Collins J, Myers C: Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors. Cancer Res 44:1702–1705, 1984PubMedGoogle Scholar
  36. 36.
    Serra J: Image analysis and mathematical morphology. Academic Press, London New York Paris San Diego San Francisco Sāo Paulo Sydney Tokyo Toronto, 1982Google Scholar
  37. 37.
    Steel GG: Growth kinetics of tumours. Oxford, Oxford University Press, pp 76–78, 1977Google Scholar
  38. 38.
    Szybalski W: X-ray sensitization by halopyrimidines. Cancer Chemother Rep 58:539–557, 1974PubMedGoogle Scholar
  39. 39.
    Tannock IF: The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Brit J Cancer 22:258–273, 1968PubMedGoogle Scholar
  40. 40.
    Tannock I, Howes A: The response of viable tumor cords to a single dose of radiation. Radiat Res 55:477–486, 1973PubMedGoogle Scholar
  41. 41.
    Thomlinson RH, Gray LH: The histological structure of some human lung cancers and the possible implication for radiotherapy. Brit J Cancer 9:539–549, 1955PubMedGoogle Scholar
  42. 42.
    Tym R: Distribution of cell doubling times in in vivo human cerebral tumors. Surg Forum 20: 445–447, 1969PubMedGoogle Scholar
  43. 43.
    Weller RO, Foy M, Cox S: The development and ultrastructure of the microvasculature in malignant gliomas. Neuropath appl Neurobiol 3:307–322, 1977Google Scholar
  44. 44.
    Yamashita T, Kuwabara T: Estimation of rate of growth of malignant brain tumors by computed tomography scanning. Surg Neurol 20:464–470, 1983PubMedGoogle Scholar
  45. 45.
    Yoshii Y, Maki Y, Tsuboi K, Tomono Y, Nakagawa K, Hoshino T: Estimation of growth fraction in human central nervous system tumors by bromodeoxyuridine. J Neurosurg 65:653–659, 1986Google Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • Yoshihiko Yoshii
    • 1
  • Kiyoshi Narushima
    • 1
  • Koji Tsuboi
    • 1
  • Yutaka Maki
    • 1
  • Kohei Sugiyama
    • 2
  1. 1.Department of Neurological Surgery, Institute of Clinical MedicineUniversity of TsukubaIbarakiJapan
  2. 2.Computer Bild Co., Ltd.TokyoJapan

Personalised recommendations